請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/73937
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 郭鐘金(Chuan-Chin Kuo) | |
dc.contributor.author | Yi-Shuan Peng | en |
dc.contributor.author | 彭奕璇 | zh_TW |
dc.date.accessioned | 2021-06-17T08:14:17Z | - |
dc.date.available | 2024-08-26 | |
dc.date.copyright | 2019-08-26 | |
dc.date.issued | 2019 | |
dc.date.submitted | 2019-08-14 | |
dc.identifier.citation | Aldrich, R. W., D. P. Corey, and C. F. Stevens. 1983. 'A reinterpretation of mammalian sodium channel gating based on single channel recording', Nature, 306: 436-41.
Aldrich, R. W., and C. F. Stevens. 1987. 'Voltage-dependent gating of single sodium channels from mammalian neuroblastoma cells', J Neurosci, 7: 418-31. Armstrong, C. M., and F. Bezanilla. 1977. 'Inactivation of the sodium channel. II. Gating current experiments', J Gen Physiol, 70: 567-90. Balser, J. R., H. B. Nuss, D. W. Orias, D. C. Johns, E. Marban, G. F. Tomaselli, and J. H. Lawrence. 1996. 'Local anesthetics as effectors of allosteric gating. Lidocaine effects on inactivation-deficient rat skeletal muscle Na channels', J Clin Invest, 98: 2874-86. Bean, B. P. 1984. 'Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state', Proc Natl Acad Sci U S A, 81: 6388-92. Bendahhou, S., T. R. Cummins, R. W. Kula, Y. H. Fu, and L. J. Ptacek. 2002. 'Impairment of slow inactivation as a common mechanism for periodic paralysis in DIIS4-S5', Neurology, 58: 1266-72. Brancati, F., E. M. Valente, N. P. Davies, A. Sarkozy, M. G. Sweeney, M. LoMonaco, A. Pizzuti, M. G. Hanna, and B. Dallapiccola. 2003. 'Severe infantile hyperkalaemic periodic paralysis and paramyotonia congenita: broadening the clinical spectrum associated with the T704M mutation in SCN4A', J Neurol Neurosurg Psychiatry, 74: 1339-41. Cahalan, M. D., and W. Almers. 1979. 'Interactions between quaternary lidocaine, the sodium channel gates, and tetrodotoxin', Biophys J, 27: 39-55. Catterall, W. A. 2000. 'From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels', Neuron, 26: 13-25. ———. 2012a. 'Sodium Channel Mutations and Epilepsy.' in th, J. L. Noebels, M. Avoli, M. A. Rogawski, R. W. Olsen and A. V. Delgado-Escueta (eds.), Jasper's Basic Mechanisms of the Epilepsies (National Center for Biotechnology Information (US) Michael A Rogawski, Antonio V Delgado-Escueta, Jeffrey L Noebels, Massimo Avoli and Richard W Olsen.: Bethesda (MD)). ———. 2012b. 'Voltage-gated sodium channels at 60: structure, function and pathophysiology', J Physiol, 590: 2577-89. ———. 2014. 'Structure and function of voltage-gated sodium channels at atomic resolution', Exp Physiol, 99: 35-51. Catterall, W. A., A. L. Goldin, and S. G. Waxman. 2005. 'International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels', Pharmacol Rev, 57: 397-409. Catterall, W. A., F. Kalume, and J. C. Oakley. 2010. 'NaV1.1 channels and epilepsy', J Physiol, 588: 1849-59. Colombo, E., S. Franceschetti, G. Avanzini, and M. Mantegazza. 2013. 'Phenytoin inhibits the persistent sodium current in neocortical neurons by modifying its inactivation properties', PLoS One, 8: e55329. Cormier, J. W., I. Rivolta, M. Tateyama, A. S. Yang, and R. S. Kass. 2002. 'Secondary structure of the human cardiac Na+ channel C terminus: evidence for a role of helical structures in modulation of channel inactivation', J Biol Chem, 277: 9233-41. Corry, B., and M. Thomas. 2012. 'Mechanism of ion permeation and selectivity in a voltage gated sodium channel', J Am Chem Soc, 134: 1840-6. Courtney, K. R., and E. F. Etter. 1983. 'Modulated anticonvulsant block of sodium channels in nerve and muscle', Eur J Pharmacol, 88: 1-9. Cummins, T. R., and F. J. Sigworth. 1996. 'Impaired slow inactivation in mutant sodium channels', Biophys J, 71: 227-36. de Lera Ruiz, M., and R. L. Kraus. 2015. 'Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications', J Med Chem, 58: 7093-118. Errington, A. C., L. Coyne, T. Stohr, N. Selve, and G. Lees. 2006. 'Seeking a mechanism of action for the novel anticonvulsant lacosamide', Neuropharmacology, 50: 1016-29. Errington, A. C., T. Stohr, C. Heers, and G. Lees. 2008. 'The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels', Mol Pharmacol, 73: 157-69. Escayg, A., and A. L. Goldin. 2010. 'Sodium channel SCN1A and epilepsy: mutations and mechanisms', Epilepsia, 51: 1650-8. Gawali, Vaibhavkumar S., Peter Lukacs, Rene Cervenka, Xaver Koenig, Lena Rubi, Karlheinz Hilber, Walter Sandtner, and Hannes Todt. 2015. 'Mechanism of Modification, by Lidocaine, of Fast and Slow Recovery from Inactivation of Voltage-Gated Na<sup>+</sup> Channels', 88: 866-79. Gellens, M. E., A. L. George, Jr., L. Q. Chen, M. Chahine, R. Horn, R. L. Barchi, and R. G. Kallen. 1992. 'Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel', Proc Natl Acad Sci U S A, 89: 554-8. George, A. L., Jr. 2005. 'Inherited disorders of voltage-gated sodium channels', J Clin Invest, 115: 1990-9. Goldin, A. L. 1999. 'Diversity of mammalian voltage-gated sodium channels', Ann N Y Acad Sci, 868: 38-50. Goldman, L., and C. L. Schauf. 1972. 'Inactivation of the sodium current in Myxicola giant axons. Evidence for coupling to the activation process', J Gen Physiol, 59: 659-75. Hanck, D. A., J. C. Makielski, and M. F. Sheets. 1994. 'Kinetic effects of quaternary lidocaine block of cardiac sodium channels: a gating current study', J Gen Physiol, 103: 19-43. ———. 2000. 'Lidocaine alters activation gating of cardiac Na channels', Pflugers Arch, 439: 814-21. Hayward, L. J., G. M. Sandoval, and S. C. Cannon. 1999. 'Defective slow inactivation of sodium channels contributes to familial periodic paralysis', Neurology, 52: 1447-53. Hebeisen, S., N. Pires, A. I. Loureiro, M. J. Bonifacio, N. Palma, A. Whyment, D. Spanswick, and P. Soares-da-Silva. 2015. 'Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: a comparison with carbamazepine, oxcarbazepine and lacosamide', Neuropharmacology, 89: 122-35. Heinemann, S. H., H. Terlau, W. Stuhmer, K. Imoto, and S. Numa. 1992. 'Calcium channel characteristics conferred on the sodium channel by single mutations', Nature, 356: 441-3. Hilber, K., W. Sandtner, O. Kudlacek, B. Schreiner, I. Glaaser, W. Schutz, H. A. Fozzard, S. C. Dudley, and H. Todt. 2002. 'Interaction between fast and ultra-slow inactivation in the voltage-gated sodium channel. Does the inactivation gate stabilize the channel structure?', J Biol Chem, 277: 37105-15. Hille, B. 1977. 'Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction', J Gen Physiol, 69: 497-515. Hodgkin, A. L., and A. F. Huxley. 1952a. 'The dual effect of membrane potential on sodium conductance in the giant axon of Loligo', J Physiol, 116: 497-506. ———. 1952b. 'A quantitative description of membrane current and its application to conduction and excitation in nerve', J Physiol, 117: 500-44. Holtkamp, D., T. Opitz, I. Niespodziany, C. Wolff, and H. Beck. 2017. 'Activity of the anticonvulsant lacosamide in experimental and human epilepsy via selective effects on slow Na(+) channel inactivation', Epilepsia, 58: 27-41. Isom, L. L., K. S. De Jongh, D. E. Patton, B. F. Reber, J. Offord, H. Charbonneau, K. Walsh, A. L. Goldin, and W. A. Catterall. 1992. 'Primary structure and functional expression of the beta 1 subunit of the rat brain sodium channel', Science, 256: 839-42. Isom, L. L., D. S. Ragsdale, K. S. De Jongh, R. E. Westenbroek, B. F. Reber, T. Scheuer, and W. A. Catterall. 1995. 'Structure and function of the beta 2 subunit of brain sodium channels, a transmembrane glycoprotein with a CAM motif', Cell, 83: 433-42. Jo, S., and B. P. Bean. 2017. 'Lacosamide Inhibition of Nav1.7 Voltage-Gated Sodium Channels: Slow Binding to Fast-Inactivated States', Mol Pharmacol, 91: 277-86. Kim, J. B. 2014. 'Channelopathies', Korean J Pediatr, 57: 1-18. Kuo, C. C. 1998. 'A common anticonvulsant binding site for phenytoin, carbamazepine, and lamotrigine in neuronal Na+ channels', Mol Pharmacol, 54: 712-21. Kuo, C. C., and B. P. Bean. 1994. 'Slow binding of phenytoin to inactivated sodium channels in rat hippocampal neurons', Mol Pharmacol, 46: 716-25. Kuo, C. C., R. S. Chen, L. Lu, and R. C. Chen. 1997. 'Carbamazepine inhibition of neuronal Na+ currents: quantitative distinction from phenytoin and possible therapeutic implications', Mol Pharmacol, 51: 1077-83. Kwong, K., and M. J. Carr. 2015. 'Voltage-gated sodium channels', Curr Opin Pharmacol, 22: 131-9. Lees, G., T. Stohr, and A. C. Errington. 2006. 'Stereoselective effects of the novel anticonvulsant lacosamide against 4-AP induced epileptiform activity in rat visual cortex in vitro', Neuropharmacology, 50: 98-110. Mantegazza, M., F. H. Yu, W. A. Catterall, and T. Scheuer. 2001. 'Role of the C-terminal domain in inactivation of brain and cardiac sodium channels', Proc Natl Acad Sci U S A, 98: 15348-53. McPhee, J. C., D. S. Ragsdale, T. Scheuer, and W. A. Catterall. 1994. 'A mutation in segment IVS6 disrupts fast inactivation of sodium channels', Proc Natl Acad Sci U S A, 91: 12346-50. ———. 1995. 'A critical role for transmembrane segment IVS6 of the sodium channel alpha subunit in fast inactivation', J Biol Chem, 270: 12025-34. Muroi, Y., and B. Chanda. 2009. 'Local anesthetics disrupt energetic coupling between the voltage-sensing segments of a sodium channel', J Gen Physiol, 133: 1-15. Narashashi, T. 1964. 'RESTORATION OF ACTION POTENTIAL BY ANODAL POLARIZATION IN LOBSTER GIANT AXONS', J Cell Comp Physiol, 64: 73-96. Niespodziany, I., N. Leclere, C. Vandenplas, P. Foerch, and C. Wolff. 2013. 'Comparative study of lacosamide and classical sodium channel blocking antiepileptic drugs on sodium channel slow inactivation', J Neurosci Res, 91: 436-43. Noda, M., T. Ikeda, T. Kayano, H. Suzuki, H. Takeshima, M. Kurasaki, H. Takahashi, and S. Numa. 1986. 'Existence of distinct sodium channel messenger RNAs in rat brain', Nature, 320: 188-92. Noda, M., S. Shimizu, T. Tanabe, T. Takai, T. Kayano, T. Ikeda, H. Takahashi, H. Nakayama, Y. Kanaoka, N. Minamino, and et al. 1984. 'Primary structure of Electrophorus electricus sodium channel deduced from cDNA sequence', Nature, 312: 121-7. O'Leary, M. E., and M. Chahine. 2018. 'Mechanisms of Drug Binding to Voltage-Gated Sodium Channels', Handb Exp Pharmacol, 246: 209-31. O'Reilly, J. P., S. Y. Wang, and G. K. Wang. 2001. 'Residue-specific effects on slow inactivation at V787 in D2-S6 of Na(v)1.4 sodium channels', Biophys J, 81: 2100-11. Olson, T. M., V. V. Michels, J. D. Ballew, S. P. Reyna, M. L. Karst, K. J. Herron, S. C. Horton, R. J. Rodeheffer, and J. L. Anderson. 2005. 'Sodium channel mutations and susceptibility to heart failure and atrial fibrillation', Jama, 293: 447-54. Payandeh, J., T. Scheuer, N. Zheng, and W. A. Catterall. 2011. 'The crystal structure of a voltage-gated sodium channel', Nature, 475: 353-8. Quandt, F N. 1988. 'Modification of slow inactivation of single sodium channels by phenytoin in neuroblastoma cells', 34: 557-65. Rogawski, M. A., A. Tofighy, H. S. White, A. Matagne, and C. Wolff. 2015. 'Current understanding of the mechanism of action of the antiepileptic drug lacosamide', Epilepsy Res, 110: 189-205. Rudy, B. 1978. 'Slow inactivation of the sodium conductance in squid giant axons. Pronase resistance', J Physiol, 283: 1-21. Sandtner, W., J. Szendroedi, T. Zarrabi, E. Zebedin, K. Hilber, I. Glaaser, H. A. Fozzard, S. C. Dudley, and H. Todt. 2004. 'Lidocaine: a foot in the door of the inner vestibule prevents ultra-slow inactivation of a voltage-gated sodium channel', Mol Pharmacol, 66: 648-57. Satin, J., J. W. Kyle, M. Chen, P. Bell, L. L. Cribbs, H. A. Fozzard, and R. B. Rogart. 1992. 'A mutant of TTX-resistant cardiac sodium channels with TTX-sensitive properties', Science, 256: 1202-5. Schauf, C. L. 1987. 'Zonisamide enhances slow sodium inactivation in Myxicola', Brain Res, 413: 185-8. Shaw, R. M., and Y. Rudy. 1997. 'Ionic mechanisms of propagation in cardiac tissue. Roles of the sodium and L-type calcium currents during reduced excitability and decreased gap junction coupling', Circ Res, 81: 727-41. Sheets, M. F., H. A. Fozzard, G. M. Lipkind, and D. A. Hanck. 2010. 'Sodium channel molecular conformations and antiarrhythmic drug affinity', Trends Cardiovasc Med, 20: 16-21. Sheets, M. F., and D. A. Hanck. 2003. 'Molecular action of lidocaine on the voltage sensors of sodium channels', J Gen Physiol, 121: 163-75. ———. 2007. 'Outward stabilization of the S4 segments in domains III and IV enhances lidocaine block of sodium channels', J Physiol, 582: 317-34. Sheets, P. L., C. Heers, T. Stoehr, and T. R. Cummins. 2008. 'Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], lidocaine, and carbamazepine', J Pharmacol Exp Ther, 326: 89-99. Silva, J. R., and S. A. Goldstein. 2013. 'Voltage-sensor movements describe slow inactivation of voltage-gated sodium channels II: a periodic paralysis mutation in Na(V)1.4 (L689I)', J Gen Physiol, 141: 323-34. Sokolov, S., T. Scheuer, and W. A. Catterall. 2005. 'Ion permeation through a voltage- sensitive gating pore in brain sodium channels having voltage sensor mutations', Neuron, 47: 183-9. Song, W., and W. Shou. 2012. 'Cardiac sodium channel Nav1.5 mutations and cardiac arrhythmia', Pediatr Cardiol, 33: 943-9. Song, W., K. S. Silver, Y. Du, Z. Liu, and K. Dong. 2011. 'Analysis of the action of lidocaine on insect sodium channels', Insect Biochem Mol Biol, 41: 36-41. Sun, Y. M., I. Favre, L. Schild, and E. Moczydlowski. 1997. 'On the structural basis for size-selective permeation of organic cations through the voltage-gated sodium channel. Effect of alanine mutations at the DEKA locus on selectivity, inhibition by Ca2+ and H+, and molecular sieving', J Gen Physiol, 110: 693-715. Szendroedi, J., W. Sandtner, T. Zarrabi, E. Zebedin, K. Hilber, S. C. Dudley, Jr., H. A. Fozzard, and H. Todt. 2007. 'Speeding the recovery from ultraslow inactivation of voltage-gated Na+ channels by metal ion binding to the selectivity filter: a foot-on-the-door?', Biophys J, 93: 4209-24. Tanabe, T., M. Noda, Y. Furutani, T. Takai, H. Takahashi, K. Tanaka, T. Hirose, S. Inayama, and S. Numa. 1984. 'Primary structure of beta subunit precursor of calf muscle acetylcholine receptor deduced from cDNA sequence', Eur J Biochem, 144: 11-7. Tateyama, M., H. Liu, A. S. Yang, J. W. Cormier, and R. S. Kass. 2004. 'Structural effects of an LQT-3 mutation on heart Na+ channel gating', Biophys J, 86: 1843-51. Toib, A., V. Lyakhov, and S. Marom. 1998. 'Interaction between duration of activity and time course of recovery from slow inactivation in mammalian brain Na+ channels', J Neurosci, 18: 1893-903. Townsend, C., and R. Horn. 1997. 'Effect of alkali metal cations on slow inactivation of cardiac Na+ channels', J Gen Physiol, 110: 23-33. Trimmer, J. S., S. S. Cooperman, S. A. Tomiko, J. Y. Zhou, S. M. Crean, M. B. Boyle, R. G. Kallen, Z. H. Sheng, R. L. Barchi, F. J. Sigworth, and et al. 1989. 'Primary structure and functional expression of a mammalian skeletal muscle sodium channel', Neuron, 3: 33-49. Vassilev, P. M., T. Scheuer, and W. A. Catterall. 1988. 'Identification of an intracellular peptide segment involved in sodium channel inactivation', Science, 241: 1658-61. Vedantham, V., and S. C. Cannon. 1999. 'The position of the fast-inactivation gate during lidocaine block of voltage-gated Na+ channels', J Gen Physiol, 113: 7-16. ———. 2000. 'Rapid and slow voltage-dependent conformational changes in segment IVS6 of voltage-gated Na(+) channels', Biophys J, 78: 2943-58. Veerman, C. C., A. A. Wilde, and E. M. Lodder. 2015. 'The cardiac sodium channel gene SCN5A and its gene product NaV1.5: Role in physiology and pathophysiology', Gene, 573: 177-87. Vilin, Y. Y., E. Fujimoto, and P. C. Ruben. 2001. 'A novel mechanism associated with idiopathic ventricular fibrillation (IVF) mutations R1232W and T1620M in human cardiac sodium channels', Pflugers Arch, 442: 204-11. Vilin, Y. Y., and P. C. Ruben. 2001. 'Slow inactivation in voltage-gated sodium channels: molecular substrates and contributions to channelopathies', Cell Biochem Biophys, 35: 171-90. Wang, Y., P. J. Jones, T. W. Batts, V. Landry, M. K. Patel, and M. L. Brown. 2009. 'Ligand-based design and synthesis of novel sodium channel blockers from a combined phenytoin-lidocaine pharmacophore', Bioorg Med Chem, 17: 7064-72. Wang, Y., J. Mi, K. Lu, Y. Lu, and K. Wang. 2015. 'Comparison of Gating Properties and Use-Dependent Block of Nav1.5 and Nav1.7 Channels by Anti-Arrhythmics Mexiletine and Lidocaine', PLoS One, 10: e0128653. Watanabe, E., A. Fujikawa, H. Matsunaga, Y. Yasoshima, N. Sako, T. Yamamoto, C. Saegusa, and M. Noda. 2000. 'Nav2/NaG channel is involved in control of salt-intake behavior in the CNS', J Neurosci, 20: 7743-51. Webb, J., and S. C. Cannon. 2008. 'Cold-induced defects of sodium channel gating in atypical periodic paralysis plus myotonia', Neurology, 70: 755-61. West, J. W., D. E. Patton, T. Scheuer, Y. Wang, A. L. Goldin, and W. A. Catterall. 1992. 'A cluster of hydrophobic amino acid residues required for fast Na(+)-channel inactivation', Proc Natl Acad Sci U S A, 89: 10910-4. Woronzow, D. S. %J Pflüger's Archiv für die gesamte Physiologie des Menschen und der Tiere. 1924. 'Über die Einwirkung des konstanten Stromes auf den mit Wasser, Zuckerlösung, Alkali- und Erdalkalichloridlösungen behandelten Nerven', 203: 300-18. Zeng, Z., E. L. Hill-Yardin, D. Williams, T. O'Brien, A. Serelis, and C. R. French. 2016. 'Effect of phenytoin on sodium conductances in rat hippocampal CA1 pyramidal neurons', J Neurophysiol, 116: 1924-36. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/73937 | - |
dc.description.abstract | 在以往的研究中已充分顯示,誘發神經興奮與動作電位的傳導主要是由電壓依賴型鈉離子通道所控制。當腦部產生異常的神經興奮時,會使得神經元過度興奮並產生類似癲癇的一些神經疾病。然而這些病患在臨床上的治療方式主要是給予典型的抗癲癇藥物,像是carbamazepine、phenytoin、lamotrigine等會去抑制電壓依賴型鈉離子通道開啟,使得興奮減少,達到治療效果。而這些典型的抗癲癇藥物也已經被證實是透過緩慢地結合在鈉離子通道的快速不活化態(fast inactivation state),並且相對於休息態(resting state)的鈉離子通道,藥物更容易結合在鈉離子通道上的快速不活化態。另外,在近十多年的研究中,也發現到lacosamide (LCM)這一種較為新穎的抗癲癇藥物,而這種藥物又與典型傳統抗癲癇藥物有所不同,被認為可能會選擇性的結合到鈉離子通道的慢速不活化態(slow inactivation state)。本篇論文首先探討,LCM抑制鈉電流的效果,量化其濃度依賴性及電壓依賴性,在不同電壓下LCM的抑制效果,可由一對一結合曲線描繪。並得到在-70 mv,LCM對於鈉離子通道的直觀解離常數(KI)約為150 µM。其次再由LCM對鈉離子通道的脫離速率與結合速率常數所得的比值,也得到相似的KI (約155 µM,-70mV)。而在不同濃度的LCM對電壓依賴不活化曲線的位移中,所得到KI值約為156 µM。因此可得知LCM對於不活化態之鈉離子通道的親和力約為150-156 µM,遠大於休息態的鈉離子通道(>10 mM)。另外,我們也利用等差電壓下給予不同時間(100毫秒或18秒)的去極化,並繪製出快速不活化曲線、慢速不活化曲線及快慢速混合不活化曲線,測出LCM主要是結合在鈉離子通道的慢速不活化態。再者,也比較給予長時間-80 mV或-10 mV的去極化,LCM對鈉離子通道相較控制組皆有較慢回復至休息態的趨勢,其中又以後者較為顯著,這也支持LCM對鈉離子通道慢速不活化態的作用大於快速不活化態。我們也針對新型藥物LCM、典型藥物phenytoin以及局部麻醉劑lidocaine做一個比較,並將兩種藥物混合使用(lacosamide+phenytoin & lacosamide+lidocaine)看是否能因為藥物作用的途徑不一樣而達到藥物加成效果。結果發現LCM及phenytoin混合後,其對鈉離子通道的抑制效果更為明顯,但在快速與慢速不活化態有不一樣的加成效果,而LCM及lidocaine混合後,其對鈉離子通道的抑制效果也更為明顯,而且至少在快速不活化態中有達到互助加成(synergistic)效果。 | zh_TW |
dc.description.abstract | It has been shown that the genesis of nerve excitation and action potential conduction is mainly controlled by voltage-gated sodium channels. Abnormal neuronal excitation may lead to neurological disorders like epilepsy. The sodium channel inhibitors such as carbamazepine, phenytoin, lamotrigine, have been the mainstay of medical treatment of epilepsy. These prototypical anticonvulsants have been shown to bind to the fast-inactivated state rather than resting state of the sodium ion channel. Lacosamide (LCM) is a new generation anticonvulsant, which also inhibits sodium channel but is different from the prototypical ones. The molecular actions of LCM on sodium channels are not clear, although selective binding to the slow-inactivated state of the sodium channel was proposed. We found that LCM dose-dependently inhibits sodium currents at more depolarized holding potentials, and the inhibitory effect could be described by different one-to-one binding curves at different holding potentials, giving an apparent dissociation constant (KI) of ~ 150 μM at -70mV for LCM binding to the inactivated sodium ion channels. The apparent dissociation constant derived from the ratio between the binding rate constant of LCM and the unbinding rate from the sodium channel is ~155 μM (at -70mV). In addition, a KI of ~156 μM is derived from the LCM concentration-dependent shift of the inactivation curve. The apparent dissociation constant of LCM for the sodium channel of the inactive state is therefore about 150-156 μM, which is much smaller than that for the resting sodium channels (>10mM). On the other hand, different inactivation curves are constructed with 100 milliseconds or 18 seconds inactivating pulses at various voltages (fast inactivation curves, slow inactivation curves and “combined’’ inactivation curves) to show that the very slow kinetics of LCM action on the inactivated sodium channels. Furthermore, LCM slows recovery from the inactivated to the resting state. The slowing effect is much more manifest with inactivating pulse at -10 than -80 mv, indicating that the effect of LCM on the slow-inactivated sodium channels is greater than on the fast-inactivated state. Last but not the least, we also explored the effect of concomitant LCM and phenytoin & LCM and lidocaine on sodium currents, and found that the LCM and phenytoin have a different action on the fast inactivation and slow inactivation of sodium channels; however, LCM and lidocaine have a synergistic inhibitory action on fast inactivation of the sodium channels. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T08:14:17Z (GMT). No. of bitstreams: 1 ntu-108-R06441001-1.pdf: 5067146 bytes, checksum: f188aafa6bc276ba79fc220dd26fe660 (MD5) Previous issue date: 2019 | en |
dc.description.tableofcontents | 口試委員會審定書(I)
致謝(II) 中文摘要(III) Abstract(V) 目錄(VII) 圖次(IX) 第一章 導論(1) 1.1 電壓依賴型鈉離子通道(1) 1.1.1 概述與種類(1) 1.1.2 結構與功能(2) 1.2 鈉離子的不活化反應(3) 1.2.1 快速不活化反應(3) 1.2.2 慢速不活化反應(5) 1.3 電壓依賴型鈉離子通道功能異常之相關疾病(7) 1.4 藥物與電壓依賴型鈉離子通道(8) 1.4.1 典型抗癲癇藥物、局部麻醉劑與鈉離子通道之關係(8) 1.4.2 Lacosamide與鈉離子通道之關係(9) 第二章 材料與方法(11) 2.1 游離神經細胞的製備(11) 2.2 玻璃電極針製備(12) 2.3 接地線、記錄電極製備(12) 2.4 沖藥管之製備(12) 2.5 藥物製備(12) 2.6 游離神經全細胞電生理記錄(13) 2.7 數據分析(14) 第三章 結果(15) 3.1 Lacosamide對於電壓依賴性鈉電流的抑制效果隨著固定電壓的增加而增強(15) 3.2 Lacosamide使鈉離子通道的快速不活化曲線往去極化方向位移(16) 3.3 藉由慢速不活化曲線的濃度依賴性位移得到lacosamide對於鈉離子通道不活化態的親和力(17) 3.4 Lacosamide大部分結合至鈉離子通道的慢速不活化態(18) 3.5 藉由不活化態恢復至休息態的時間得到lacosamide對於鈉離子通道快速及慢速不活化態的親和力(20) 3.6 Lacosamide與phenytoin混合使用對於快速與慢速不活化通道具有不同的加成效果(21) 3.7 Lacosamide與lidocaine混合使用在-80 mV下具有互助加成效果(23) 第四章 討論(26) 4.1 Lacosamide對於鈉離子通道的基本作用模式(26) 4.2 Lacosamide對於不同狀態鈉離子通道下的親和力(28) 4.3 Lacosamide與phenytoin之間的相互作用(30) 4.4 Lacosamide與lidocaine之間的相互作用(31) 4.5 比較Lacosamide、phenytoin與lidocaine之間的關係(33) 參考資料(66) | |
dc.language.iso | zh-TW | |
dc.title | Lacosamide抑制鈉離子通道之分子機制 | zh_TW |
dc.title | The mechanisms underlying the inhibitory effect of lacosamide on the voltage-gated sodium channels | en |
dc.type | Thesis | |
dc.date.schoolyear | 107-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 蔡明正(Ming-Zheng Tsai),楊雅晴(Ya-Chin Yang) | |
dc.subject.keyword | 癲癇,鈉離子通道,快速不活化態,慢速不活化態, | zh_TW |
dc.subject.keyword | epilepsy,anticonvulsant,sodium channel,lacosamide,phenytoin,lidocaine,fast inactivation,slow inactivation, | en |
dc.relation.page | 72 | |
dc.identifier.doi | 10.6342/NTU201901556 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2019-08-15 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 生理學研究所 | zh_TW |
顯示於系所單位: | 生理學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-108-1.pdf 目前未授權公開取用 | 4.95 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。